Biosimilar Copay Programs

EP: 1.Comparing Biologics and Biosimilars

EP: 2.Biosimilar Utilization and Inventory Management

EP: 3.Operationalizing Biosimilars in Specialty Pharmacies

EP: 4.Advice for States that Require Prior Prescriber Approval for Substitution

EP: 5.Key Factors to Consider when Switching to Biosimilars

EP: 6.Pharmacy and Provider Collaboration

Video content above is prompted by the following:

• How do copay programs impact the adoption of biosimilars for patients, and what role can the pharmacy staff play in educating patients about these programs?